Home › Atrial Fibrillation › Washington
Atrial Fibrillation clinical trials in Washington
10 studies for Atrial Fibrillation are looking for participants at sites in Washington.
Cities in Washington
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- St. Joseph Medical Center Tacoma, Tacoma
RecruitingPhase 3
Ages 22 to 85 · All sexes · Updated Sep 30, 2026 · NCT05836987A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
- Swedish Heart and Vascular Clinic, Seattle
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07217067Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- University of Washington-Seattle, Seattle
- MultiCare Institute for Research & Innovation, Tacoma
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT04088071PULSED AF Post-Approval Study
- Confluence Health Hospital Central Campus, Wenatchee
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06578104The Fourth Left Atrial Appendage Occlusion Study
- CommonSpirit Health Research Institute, Tacoma
Recruiting
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05963698Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigational site 9826, Puyallup
- Anthos Investigative Site 9926, Redmond
- Anthos Investigative Site 1073, Tacoma
RecruitingPhase 3
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200Medtronic Terminate AF Study
- Virginia Mason Heart Institute, Seattle
- Swedish Medical Center, Seattle
Recruiting
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT03546374Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- Harborview Medical Center, Seattle
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046Sleep Apnea Triggers of Atrial Fibrillation: N-of-1 Randomized Control Trial (SPARTA):
- University of Washington, Seattle
Recruiting
Ages 18 to 85 · All sexes · Updated Apr 13, 2026 · NCT07087587The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
- Multicare Health Systems-Pulse Heart, Puyallup
- Franciscan Heart and Vascular Associates, Tacoma
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 31, 2025 · NCT06324201From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.